Tipiracil HCl

Overview

Tipiralacil, also known as TPI, is a thymidine phosphorylase inhibitor (TPI). Tipiracil is one of the active components in TAS-102, which is an anticancer drug candidate currently in clinical trials. TAS-102 consists of the cytotoxin Trifluridine and the thymidine phosphorylase inhibitor (TPI) tipiracil. Trifluridine is incorporated into DNA during DNA synthesis and inhibits tumor cell growth. Tipiracil protects trifluridine from being broken down when taken orally.

Application

Products > Drug Discovery > Inhibitor | Products > Drug Discovery > Inhibitor | Endocrinology and Metabolic Disease | Nucleoside Antimetabolite/Analog

Product Information

• Catalog No.: B0084-424412
• CAS No.: 183204-72-0
• Molecular Formula: C9H12Cl2N4O2
• Molecular Weight: 279.121
• Purity: 0.99

Source

Original product source